This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Edwards Lifesciences Corp (EW)

NYSE: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 391.70M 293.20M 236.70M 218.00M
Operating Gains/Losses 13.60M 14.20M 22.20M 20.00M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 8.50M -26.50M -53.70M -34.20M
(Increase) Decrease in Inventories -44.40M -21.70M -57.00M -36.80M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 50.30M 41.90M 61.70M 63.60M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 2.50M 5.00M -1.30M 8.80M
Other Non-Cash Items -22.90M -10.50M 27.90M -30.80M
Net Cash From Continuing Operations 472.70M 373.80M 314.50M 251.40M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 472.70M 373.80M 314.50M 251.40M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 526.40M 662.30M 349.90M 0.00
Purchases of Property, Plant & Equipment -110.10M -127.70M -90.60M -63.00M
Acquisitions 0.00 -36.60M -42.60M 0.00
Purchases of Short-Term Investments -823.20M -592.60M -643.30M 0.00
Other Cash from Investing Activities -3.10M 3.30M 7.00M 6.60M
Cash Provided by Financing Activities
Net Cash From Investing Activities -412.70M -90.50M -412.80M -61.50M
Issuance of Debt 1.30B 407.00M 526.10M 254.40M
Cash Used for Financing Activities
Issuance of Capital Stock 45.50M 100.10M 59.50M 92.10M
Repayment of Long-Term Debt -895.40M -367.50M -421.70M -302.80M
Repurchase of Capital Stock -496.90M -344.10M -303.40M -200.00M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 76.70M 48.90M 4.30M 52.40M
Net Cash From Financing Activities 34.90M -155.60M -135.20M -103.90M
Effect of Exchange Rate Changes 14.60M 12.00M 8.60M -24.00M
Net Change in Cash & Cash Equivalents 109.50M 139.70M -224.90M 62.00M
EW News

EW Edwards Lifesciences Corp

Analysts Ratings for EW

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 10 10 11 11
Moderate Buy 0 0 0 0
Hold 7 7 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET EW ANALYST REPORT

Brokerage Partners

EW Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs